Friday, September 30, 2016

Premarin


Premarin is a brand name of conjugated estrogens, approved by the FDA in the following formulation(s):


PREMARIN (estrogens, conjugated - injectable; injection)



  • Manufacturer: WYETH PHARMS INC

    Approved Prior to Jan 1, 1982

    Strength(s): 25MG/VIAL [RLD]

PREMARIN (estrogens, conjugated - tablet; oral)



  • Manufacturer: WYETH PHARMS INC

    Approved Prior to Jan 1, 1982

    Strength(s): 0.3MG, 0.625MG [RLD], 1.25MG [RLD]


  • Manufacturer: WYETH PHARMS INC

    Approval date: January 26, 1984

    Strength(s): 0.9MG [RLD]


  • Manufacturer: WYETH PHARMS INC

    Approval date: July 16, 2003

    Strength(s): 0.45MG

Has a generic version of Premarin been approved?


No. There is currently no therapeutically equivalent version of Premarin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Premarin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Premarin.

See also...

  • Premarin Consumer Information (Drugs.com)
  • Premarin Consumer Information (Wolters Kluwer)
  • Premarin Tablets Consumer Information (Wolters Kluwer)
  • Premarin Consumer Information (Cerner Multum)
  • Conjugated Estrogens Consumer Information (Wolters Kluwer)
  • Conjugated Estrogens (Synthetic A) Consumer Information (Wolters Kluwer)
  • Conjugated Estrogens (Synthetic B) Consumer Information (Wolters Kluwer)
  • Conjugated Estrogens Tablets Consumer Information (Wolters Kluwer)
  • Conjugated estrogens Consumer Information (Cerner Multum)

Stanalin




Stanalin may be available in the countries listed below.


Ingredient matches for Stanalin



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Stanalin in the following countries:


  • Indonesia

International Drug Name Search


Leukemia Medications


Definition of Leukemia:

Any of a group of diseases of the reticuloendothelial system involving uncontrolled proliferation of white blood cells (leukocytes).


For information about a specific type of leukemia see one of the following:


  • chronic myelogenous leukemia (CML)

  • hairy cell leukemia

  • chronic lymphocytic leukemia (CLL)

  • acute lymphocytic leukemia

  • acute nonlymphocytic leukemia (AML)

  • chronic myelomonocytic leukemia

See also Leukemia Resources.

Drugs associated with Leukemia

The following drugs and medications are in some way related to, or used in the treatment of Leukemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Leukemia

  • Acute Lymphoblastic Leukemia (10 drugs)

  • Acute Lymphocytic Leukemia (14 drugs)

  • Acute Myeloblastic Leukemia (1 drug)

  • Acute Myeloid Leukemia (8 drugs in 2 topics)

  • Acute Nonlymphocytic Leukemia (13 drugs)

  • Chronic Eosinophilic Leukemia (1 drug)

  • Chronic Lymphocytic Leukemia (24 drugs in 2 topics)

  • Chronic Myelogenous Leukemia (16 drugs)

  • Hairy Cell Leukemia (5 drugs)

  • Meningeal Leukemia (3 drugs)

Learn more about Leukemia





Drug List:


Dilutol




Dilutol may be available in the countries listed below.


Ingredient matches for Dilutol



Enoxaparin

Enoxaparin sodium salt (a derivative of Enoxaparin) is reported as an ingredient of Dilutol in the following countries:


  • Argentina

  • Ecuador

Torasemide

Torasemide is reported as an ingredient of Dilutol in the following countries:


  • Spain

Torasemide sodium salt (a derivative of Torasemide) is reported as an ingredient of Dilutol in the following countries:


  • Spain

International Drug Name Search